Q2 2019 Holdings
Filed 2019-08-14 | 52 holdings | $285.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $159.5M | 2,198,094 | 55.8% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $29.7M | 1,120,346 | 10.4% |
| Apyx MED Corp(APYX) | COM | 03837C106 | $22.8M | 3,399,899 | 8.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $21.7M | 844,289 | 7.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $17.8M | 807,870 | 6.2% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $11.5M | 5,533,093 | 4.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $11.1M | 988,319 | 3.9% |
| Caredx Inc(CDNA) | COM | 14167L103 | $5.6M | 154,616 | 1.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.5M | 31,448 | 1.6% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $248.8K | 16,587,491 | 0.1% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $141.2K | 3,137,361 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $96.9K | 6,152,103 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $92.6K | 3,355,466 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $91.8K | 604,236 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $91.0K | 3,521,856 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $75.1K | 6,320,350 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $70.8K | 1,561,918 | 0.0% |
| Axonics Modulation Tech Inc(AXNX*) | COM | 05465P101 | $62.9K | 1,534,605 | 0.0% |
| Masimo Corp(MASI) | COM | 574795100 | $55.4K | 372,258 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $49.2K | 2,606,771 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $41.4K | 1,883,180 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $40.2K | 2,054,932 | 0.0% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $37.2K | 13,864,383 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $36.3K | 723,455 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $33.9K | 3,722,950 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $30.8K | 2,439,250 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $30.3K | 10,084,214 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $30.2K | 82,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $26.3K | 255,270 | 0.0% |
| Fluidigm Corp del(LAB) | COM | 34385P108 | $25.6K | 2,077,471 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $18.9K | 368,040 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $18.6K | 2,011,340 | 0.0% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $14.7K | 507,007 | 0.0% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $14.7K | 376,647 | 0.0% |
| Quotient LTD | SHS | G73268107 | $14.4K | 1,544,047 | 0.0% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $13.1K | 93,912 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $12.4K | 339,156 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $11.3K | 144,595 | 0.0% |
| Silk Road Medical Inc | COM | 82710M100 | $10.8K | 223,722 | 0.0% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $10.5K | 376,586 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $9.0K | 270,948 | 0.0% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $6.3K | 597,216 | 0.0% |
| Chardan Healthcare Acquisiti | UNIT 12/13/2023 | 15957A207 | $6.1K | 600,000 | 0.0% |
| Personalis Inc(PSNL) | COM | 71535D106 | $6.1K | 225,000 | 0.0% |
| Motus GI Hldgs Inc | COM | 62014P108 | $3.4K | 1,126,144 | 0.0% |
| Vivus Inc 4.5 05/01/2020 | NOTE 4.500% 5/0 | 928551AA8 | $3.1K | 4,000,000 | 0.0% |
| Neuronetics Inc(STIM) | COM | 64131A105 | $2.1K | 168,274 | 0.0% |
| Viveve MED Inc | COM NEW | 92852W204 | $1.7K | 4,480,565 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $1.4K | 159,247 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $835 | 145,225 | 0.0% |